Das Gupta A, Sinha R, Shrivastava D L, De S P, Taneja B L, Rao M S, Abou-Gareeb A H
Bull World Health Organ. 1967;37(3):371-85.
To assess the effectiveness of cholera vaccines, 2 controlled field trials were made in Calcutta-an endemic area-during 1964 and 1965. Three Indian vaccines of which 1 was grown on casein hydrolysate and 2 on agar, a freeze-dried vaccine from the Walter Reed Army Institute of Research (WRAIR), Washington, D.C., and an El Tor vaccine from the Philippines were used, with typhoid-paratyphoid (TAB) vaccine as a control. The 210 112 volunteers were vaccinated subcutaneously with a single dose of one of the vaccines.In the 1964 trial, the number of bacteriologically confirmed cases was not enough to show statistically significant differences in incidence between the 5 vaccine groups and the control group. However, the WRAIR freeze-dried vaccine protected about 40% of the vaccinees for 6 months after vaccination, although the efficacy was higher (57%) during the first 3 months than during the subsequent 3 months (28%). Agar-grown vaccine, produced by the Central Research Institute, Kasauli, was 37% efficacious.In the 1965 trial, owing to the small number of cases in the study area, the Kasauli vaccine was the only one to show statistically significant protection (40%).
为评估霍乱疫苗的有效性,1964年和1965年在霍乱流行地区加尔各答进行了两项对照现场试验。使用了三种印度疫苗,其中一种在酪蛋白水解物上培养,两种在琼脂上培养,一种来自华盛顿特区沃尔特·里德陆军研究所(WRAIR)的冻干疫苗,以及一种来自菲律宾的埃尔托型疫苗,并以伤寒-副伤寒(TAB)疫苗作为对照。210112名志愿者皮下接种了其中一种疫苗的单剂量。在1964年的试验中,细菌学确诊病例数不足以显示五个疫苗组与对照组在发病率上有统计学显著差异。然而,WRAIR冻干疫苗在接种后6个月内保护了约40%的接种者,尽管在前3个月的效力较高(57%),而在随后3个月则为28%。由卡萨利中央研究所生产的琼脂培养疫苗的效力为37%。在1965年的试验中,由于研究地区病例数较少,卡萨利疫苗是唯一显示出统计学显著保护作用(40%)的疫苗。